138 related articles for article (PubMed ID: 29457276)
1. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
[TBL] [Abstract][Full Text] [Related]
2. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Maiti TK; Bhutia SK
Tumour Biol; 2017 May; 39(5):1010428317701634. PubMed ID: 28459216
[TBL] [Abstract][Full Text] [Related]
3. p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer.
Sinha N; Meher BR; Naik PP; Panda PK; Mukhapadhyay S; Maiti TK; Bhutia SK
Phytomedicine; 2019 Mar; 55():179-190. PubMed ID: 30668428
[TBL] [Abstract][Full Text] [Related]
4. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway.
Panigrahi DP; Bhol CS; R N; Nagini S; Patil S; Maiti TK; Bhutia SK
Int J Biol Macromol; 2020 Jul; 155():1123-1132. PubMed ID: 31715238
[TBL] [Abstract][Full Text] [Related]
5. Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.
Panda PK; Behera B; Meher BR; Das DN; Mukhopadhyay S; Sinha N; Naik PP; Roy B; Das J; Paul S; Maiti TK; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Feb; 56(2):389-401. PubMed ID: 27182794
[TBL] [Abstract][Full Text] [Related]
6. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
[TBL] [Abstract][Full Text] [Related]
7. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
[TBL] [Abstract][Full Text] [Related]
8. Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.
Panda PK; Patra S; Naik PP; Praharaj PP; Mukhopadhyay S; Meher BR; Gupta PK; Verma RS; Maiti TK; Bhutia SK
J Cell Physiol; 2020 Mar; 235(3):2776-2791. PubMed ID: 31544977
[TBL] [Abstract][Full Text] [Related]
9. Portulaca oleracea extract can inhibit nodule formation of colon cancer stem cells by regulating gene expression of the Notch signal transduction pathway.
Jin H; Chen L; Wang S; Chao D
Tumour Biol; 2017 Jul; 39(7):1010428317708699. PubMed ID: 28714363
[TBL] [Abstract][Full Text] [Related]
10. Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.
Min SJ; Lim JY; Kim HR; Kim SJ; Kim Y
Int J Mol Sci; 2015 Apr; 16(5):9976-97. PubMed ID: 25941936
[TBL] [Abstract][Full Text] [Related]
11. Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer.
Bhutia SK; Behera B; Nandini Das D; Mukhopadhyay S; Sinha N; Panda PK; Naik PP; Patra SK; Mandal M; Sarkar S; Menezes ME; Talukdar S; Maiti TK; Das SK; Sarkar D; Fisher PB
Int J Cancer; 2016 Jul; 139(2):457-66. PubMed ID: 26914517
[TBL] [Abstract][Full Text] [Related]
12. Abrus agglutinin promotes irreparable DNA damage by triggering ROS generation followed by ATM-p73 mediated apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Das DN; Mukhopadhyay S; Maiti TK; Shanmugam MK; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Nov; 56(11):2400-2413. PubMed ID: 28543759
[TBL] [Abstract][Full Text] [Related]
13. BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.
Kim BR; Oh SC; Lee DH; Kim JL; Lee SY; Kang MH; Lee SI; Kang S; Joung SY; Min BW
Tumour Biol; 2015 Dec; 36(12):9475-86. PubMed ID: 26124007
[TBL] [Abstract][Full Text] [Related]
14. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
Osman J; Bellamkonda K; Liu Q; Andersson T; Sjölander A
Anticancer Res; 2019 Apr; 39(4):1719-1728. PubMed ID: 30952711
[TBL] [Abstract][Full Text] [Related]
15. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
16. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
17. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres.
Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
Mol Cancer; 2010 Aug; 9():212. PubMed ID: 20691072
[TBL] [Abstract][Full Text] [Related]
18. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
[TBL] [Abstract][Full Text] [Related]
19. Bile acid: a potential inducer of colon cancer stem cells.
Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
[TBL] [Abstract][Full Text] [Related]
20. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
